AstraZeneca Plc is spinning off a company to develop drugs for immune disorders with as much as $250 million from a group of investors.
from Bloomberg http://ift.tt/2t9g2zF
Subscribe to:
Post Comments (Atom)
Where to watch the French Open: Live streams, players, venue, free options
When you buy through our links, Business Insider may earn an affiliate commission. Learn more Coco Gauff returns to the French Open to defen...
-
Student-loan borrowers said they're worried about higher payments without the SAVE plan. Aaron Hawkins/Getty Images/iStockphoto Tru...
-
Big Tech is emerging a winner in the new H-1B system, while early-stage startups could lose out. Matthias Balk/nirat/Getty/Getty Images ...
-
Healthcare costs will change for Americans in 2026. Reza Estakhrian/Getty Images Health insurance costs are expected to rise for Americ...
No comments:
Post a Comment